← All Sponsors
SPONSOR

Hua Li

Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Hepatocellular CarcinomaPersonalized Cancer Treatment
NCT05803928 Phase 1
Recruiting

Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies

Hepatocellular Carcinoma
China View Trial →
NCT06232213
Recruiting

Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model

Personalized Cancer Treatment
China View Trial →